PCN32 COST-MINIMIZATION ANALYSIS OF ORAL VS. IV FLUDARABINE FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL) IN BRAZIL
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63462-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)63462-6/fulltext
Section Title :
Section Order :
312
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63462-6&doi=10.1016/S1098-3015(10)63462-6